Patterns of Symptom Management Medication Receipt at End-of-Life Among Medicare Beneficiaries with Lung Cancer.
Older adults with advanced lung cancer experience high symptom burden at end-of-life (EOL), yet hospice enrollment often happens late or not at all. Receipt of medications to manage symptoms in the outpatient setting, outside of the Medicare hospice benefit, has not been described. We examined patterns of symptom management medication receipt at EOL for older adults who died with lung cancer. This retrospective cohort used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to identify decedents diagnosed with lung cancer at age ≥67 between 01/2008-12/2013 who survived ≥6 months after diagnosis. Using Medicare Part B and D claims, we identified monthly receipt of outpatient medications for symptomatic management of pain, emotional distress, fatigue, dyspnea, anorexia, and nausea/vomiting. Multivariable logistic regression estimated associations between medication receipt and patient demographic characteristics, comorbidity, and concurrent therapy. Of the 16,246 included patients, large proportions received medications for dyspnea (70.7%), pain (62.5%), and emotional distress (49.4%), with lower prevalence for other symptoms. Medication receipt increased from six to one months prior to death. Women, and dual Medicaid enrolled were more likely to receive medications for pain, emotional distress, dyspnea, and nausea/vomiting. Receipt of symptom management medications decreased with increasing age and minority race/ethnicity. Symptom management medication receipt was common and increasing toward EOL. Lower use by males, older adults, and non-whites may reflect poor access or poor patient-provider communication. Further research is needed to understand these patterns and assess adequacy of symptom management in the outpatient setting.